Literature DB >> 33479669

Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.

Ekaterina S Sazanova1, Iuliia A Gracheva1, Diane Allegro2, Pascale Barbier2, Sébastien Combes3,4, Elena V Svirshchevskaya5, Alexey Yu Fedorov1.   

Abstract

We describe an attempt to apply the concept of covalent binding towards the highly active allocolchicinoids selected on the basis of SAR analysis of previously synthesized molecules. To achieve the irreversible binding of the agent to the cysteine residues of the colchicine site of tubulin protein, we synthesized a number of new allocolchicinoids bearing the acceptor moiety. Some of the new derivatives possess cytotoxic activity against COLO-357, BxPC-3, HaCaT, and HEK293 cell lines in a low nanomolar range of concentrations. A substoichiometric mode of microtubule assembly inhibition was demonstrated. The most active compounds possess close to colchicine general toxicity on mice. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479669      PMCID: PMC7578708          DOI: 10.1039/d0md00060d

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  38 in total

Review 1.  Nanotransporters for drug delivery.

Authors:  Tessa Lühmann; Lorenz Meinel
Journal:  Curr Opin Biotechnol       Date:  2016-01-11       Impact factor: 9.740

Review 2.  Developing irreversible inhibitors of the protein kinase cysteinome.

Authors:  Qingsong Liu; Yogesh Sabnis; Zheng Zhao; Tinghu Zhang; Sara J Buhrlage; Lyn H Jones; Nathanael S Gray
Journal:  Chem Biol       Date:  2013-02-21

Review 3.  Dendrimer-based nanocarriers: a versatile platform for drug delivery.

Authors:  Hao-Jui Hsu; Jason Bugno; Seung-Ri Lee; Seungpyo Hong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-04-29

4.  Tumor therapy: targeted drug delivery systems.

Authors:  Liangliang Dai; Junjie Liu; Zhong Luo; Menghuan Li; Kaiyong Cai
Journal:  J Mater Chem B       Date:  2016-09-12       Impact factor: 6.331

5.  Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.

Authors:  Catherine Rappl; Pascale Barbier; Véronique Bourgarel-Rey; Catherine Grégoire; Robert Gilli; Manon Carre; Sébastien Combes; Jean-Pierre Finet; Vincent Peyrot
Journal:  Biochemistry       Date:  2006-08-01       Impact factor: 3.162

6.  Synthesis and cytostatic properties of polyfunctionalized furanoallocolchicinoids.

Authors:  Iuliia A Gracheva; Iuliia V Voitovich; Vladimir I Faerman; Nikolay S Sitnikov; Ekaterina V Myrsikova; Hans-Gunther Schmalz; Elena V Svirshevskaya; Alexey Yu Fedorov
Journal:  Eur J Med Chem       Date:  2016-11-16       Impact factor: 6.514

7.  Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents.

Authors:  C Stengel; S P Newman; M P Leese; B V L Potter; M J Reed; A Purohit
Journal:  Br J Cancer       Date:  2009-12-22       Impact factor: 7.640

8.  Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.

Authors:  Marie L Antony; Joomin Lee; Eun-Ryeong Hahm; Su-Hyeong Kim; Adam I Marcus; Vandana Kumari; Xinhua Ji; Zhen Yang; Courtney L Vowell; Peter Wipf; Guy T Uechi; Nathan A Yates; Guillermo Romero; Saumendra N Sarkar; Shivendra V Singh
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

Review 9.  ATP binding cassette transporters and drug resistance in breast cancer.

Authors:  F Leonessa; R Clarke
Journal:  Endocr Relat Cancer       Date:  2003-03       Impact factor: 5.678

Review 10.  Apoptosis in cancer: from pathogenesis to treatment.

Authors:  Rebecca S Y Wong
Journal:  J Exp Clin Cancer Res       Date:  2011-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.